Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Express Scripts
McKinsey
Dow
Johnson and Johnson

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

Litigation Details for Church & Dwight Co., Inc. v. SPD Swiss Precision Diagnostics GMBH (S.D.N.Y. 2014)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Church & Dwight Co., Inc. v. SPD Swiss Precision Diagnostics GMBH (S.D.N.Y. 2014)

Docket   Start Trial Date Filed 2014-01-29
Court District Court, S.D. New York Date Terminated 2018-09-05
Cause 15:1114 Trademark Infringement (Lanham Act) Assigned To Alison Julie Nathan
Jury Demand Plaintiff Referred To Ona T. Wang
Parties CHURCH & DWIGHT CO., INC.; SPD SWISS PRECISION DIAGNOSTICS GMBH
Patents 6,028,222
Attorneys Alice H. Wang; Baldassare Vinti; David Mehretu; Harold Paul Weinberger; Ira Jay Levy; Irene Weintraub; J. Anthony Downs; Jeffrey G. Knowles; Jeffrey H. Warshafsky; Julia D. Greer; Lawrence I. Weinstein; Michael T. Mervis; Norman Christopher Simon; Qian Jennifer Yang; Richard Martin Goldstein; Samantha Vanessa Ettari; Victoria L. Loughery
Firms Goodwin Procter LLP; Goodwin Procter, LLP (NYC), the New York Times Building; Kramer Levin Naftalis and Frankel LLP; Proskauer Rose LLP; Proskauer Rose LLP (NY)
Link to Docket External link to docket
Small Molecule Drugs cited in Church & Dwight Co., Inc. v. SPD Swiss Precision Diagnostics GMBH
The small molecule drug covered by the patent cited in this case is   Start Trial .

Details for Church & Dwight Co., Inc. v. SPD Swiss Precision Diagnostics GMBH (S.D.N.Y. 2014)

Date Filed Document No. Description Snippet Link To Document
2017-11-13 542 Declaration Reexamination of U.S. Patent No. 6,028,222 (November 2013) before United States Patent and Trademark Office…Annual Sedona Conference on Patent Litigation, Sedona, AZ, October 2004. “Patent Damages: Engineering and… 5–15. January–March 2015. “Pharma and biotech patent litigation.” With D. Schüssler-Langeheine, D. Nemec…Price Review Regime.” 9th Annual Forum on Pharma Patents, Canadian Institute, Toronto, Canada, November …Profits, Consequential Damages, Damages for Non-Patented Items, Best Practices for the Use of Experts. External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Merck
Express Scripts
Medtronic
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.